Thymalfasin for the treatment of chronic hepatitis C infection.

about

Thymosin Alpha-1 in Combination with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients Who have Failed to Prior Pegylated Interferon and Ribavirin Treatment.

P2860

Q40608137-C53C2A7E-0C42-4E0C-8838-67D89C0CEAC8

P2860

Thymalfasin for the treatment of chronic hepatitis C infection.

Item

http://www.wikidata.org/entity/Q36322104

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Thymalfasin for the treatment of chronic hepatitis C infection.

@ast

Thymalfasin for the treatment of chronic hepatitis C infection.

@en

type

Item

label

Thymalfasin for the treatment of chronic hepatitis C infection.

@ast

Thymalfasin for the treatment of chronic hepatitis C infection.

@en

prefLabel

Thymalfasin for the treatment of chronic hepatitis C infection.

@ast

Thymalfasin for the treatment of chronic hepatitis C infection.

@en

P1476

Thymalfasin for the treatment of chronic hepatitis C infection.

@en

P2093

Vinod K Rustgi

http://www.w3.org/2001/XMLSchema#string

P2860

Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C.

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Thymosin-alpha1 stimulates maturation of CD34+ stem cells into CD3+4+ cells in an in vitro thymic epithelia organ coculture model.

Activation of IKK by thymosin alpha1 requires the TRAF6 signalling pathway.

Developments in the treatment of chronic hepatitis C.

Treatment of chronic hepatitis C in nonresponders to previous therapy.

Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment.

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study.

P304

885-892

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.3.6.885

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16307501

http://www.w3.org/2001/XMLSchema#string

Thymalfasin for the treatment of chronic hepatitis C infection.

about

P2860

P2860

Thymalfasin for the treatment of chronic hepatitis C infection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698